Literature DB >> 10998707

Chronic Daily Headache: Theory to Therapy.

.   

Abstract

Headaches are among the most frequent symptoms for which Americans seek physician advice and treatment. Although headache may herald a serious underlying organic or psychological illness, it more commonly represents a primary disorder of brain stem nociceptive processing and modulation. Chronic daily headache characteristically develops gradually from episodic tension or migraine-type headaches into a refractory syndrome often associated with medication overuse and disability. Better understanding of the pathophysiology and evolutionary mechanisms involved in the development of chronic headache has led to recommended changes in nosology originally proposed by the International Headache Society (IHS). Recent scientific and clinical observations prompting revised classification have also led to the integration of pathoanatomic models, which explain persistent headache. Strategies for the management of chronic craniofacial pain should emphasize key behavioral and attitudinal changes and avoidance of medication overusage.

Entities:  

Year:  1999        PMID: 10998707     DOI: 10.1007/s11916-999-0076-z

Source DB:  PubMed          Journal:  Curr Rev Pain        ISSN: 1069-5850


  37 in total

1.  Development of chronic daily headache: a clinical study.

Authors:  E L Spierings; M Schroevers; P C Honkoop; M Sorbi
Journal:  Headache       Date:  1998 Jul-Aug       Impact factor: 5.887

Review 2.  The International Headache Society classification of chronic daily and near-daily headaches: a critique of the criticism.

Authors:  J Olesen; B K Rasmussen
Journal:  Cephalalgia       Date:  1996-10       Impact factor: 6.292

3.  Abrupt outpatient withdrawal of medication in analgesic-abusing migraineurs.

Authors:  R Hering; T J Steiner
Journal:  Lancet       Date:  1991-06-15       Impact factor: 79.321

Review 4.  "Hemicrania continua": a clinical review.

Authors:  C Bordini; F Antonaci; L J Stovner; H Schrader; O Sjaastad
Journal:  Headache       Date:  1991-01       Impact factor: 5.887

5.  Vasoactive peptide release in the extracerebral circulation of humans during migraine headache.

Authors:  P J Goadsby; L Edvinsson; R Ekman
Journal:  Ann Neurol       Date:  1990-08       Impact factor: 10.422

Review 6.  Daily chronic headache.

Authors:  J R Saper
Journal:  Neurol Clin       Date:  1990-11       Impact factor: 3.806

7.  Comprehensive inpatient treatment for intractable migraine: a prospective long-term outcome study.

Authors:  A E Lake; J R Saper; S F Madden; C Kreeger
Journal:  Headache       Date:  1993-02       Impact factor: 5.887

8.  The trigeminovascular system and migraine: studies characterizing cerebrovascular and neuropeptide changes seen in humans and cats.

Authors:  P J Goadsby; L Edvinsson
Journal:  Ann Neurol       Date:  1993-01       Impact factor: 10.422

9.  Human in vivo evidence for trigeminovascular activation in cluster headache. Neuropeptide changes and effects of acute attacks therapies.

Authors:  P J Goadsby; L Edvinsson
Journal:  Brain       Date:  1994-06       Impact factor: 13.501

10.  Botulinum toxin A, adjunctive therapy for refractory headaches associated with pericranial muscle tension.

Authors:  A H Wheeler
Journal:  Headache       Date:  1998-06       Impact factor: 5.887

View more
  1 in total

1.  Quantitative neuromagnetic signatures of aberrant cortical excitability in pediatric chronic migraine.

Authors:  Kimberly A Leiken; Jing Xiang; Emily Curry; Hisako Fujiwara; Douglas F Rose; Janelle R Allen; Joanne E Kacperski; Hope L O'Brien; Marielle A Kabbouche; Scott W Powers; Andrew D Hershey
Journal:  J Headache Pain       Date:  2016-04-26       Impact factor: 7.277

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.